Comprehensive multi-platform tyrosine kinase profiling reveals novel actionable FGFR aberrations across sarcomas affecting the young.

Saved in:
Bibliographic Details
Title: Comprehensive multi-platform tyrosine kinase profiling reveals novel actionable FGFR aberrations across sarcomas affecting the young.
Authors: Fordham AM; Children's Cancer Institute Australia Randwick Australia., Brown LM; Children's Cancer Institute Australia Sydney Australia., Mayoh C; Children's Cancer Institute Australia Sydney, NSW Australia., Salib A; Children's Cancer Institute Australia for Medical Research Sydney, NSW Australia., Barger ZA; Children's Cancer Institute Australia Randwick Australia., Wong M; Children's Cancer Institute Australia Kensington Australia., Lim Kam Sian TCC; Monash University Clayton, Victoria Australia., Hu C; Monash University Clayton Australia., Xie J; Children's Cancer Institute Australia Sydney, NSW Australia., Gunther K; University of New South Wales Sydney, NSW Australia., Trebilcock P; Children's Cancer Institute Australia Randwick Australia., Terry RL; Children's Cancer Institute Australia Randwick Australia., Barahona P; Children's Cancer Institute Australia Sydney, NSW Australia., Ajuyah P; Children's Cancer Institute Australia Sydney, NSW Australia., Sherstyuk A; Thermo Fisher Scientific Sydney, NSW Australia., Avila A; Children's Cancer Institute Australia Kensington, NSW Australia., Cadiz R; Children's Cancer Institute Australia Sydney, NSW Australia., Perkins CM; Children's Cancer Institute Sydney, NSW Australia., Gifford AJ; Children's Cancer Institute Australia Randwick, NSW Australia., Mao J; Children's Cancer Institute Australia Kensington, NSW Australia., Dolman MEM; Children's Cancer Institute Australia Kensington, NSW Australia., Zhao A; Children's Cancer Institute Australia Randwick Australia., O'Regan LP; Children's Cancer Institute Australia Randwick Australia., Gorgels D; KU Leuven Leuven Belgium., Lau LMS; Sydney Children's Hospital Randwick, NSW Australia., Ziegler DS; Sydney Children's Hospital Randwick, NSW Australia., Haber M; Children's Cancer Institute Australia RANDWICK, NSW Australia., Tyrrell V; Children's Cancer Institute Australia Australia., Lock RB; Children's Cancer Institute Australia Sydney, NSW Australia., Cowley MJ; Children's Cancer Institute Australia Randwick, NSW Australia., Nicholls W; Queensland Children's Hospital Brisbane, Queensland Australia., Daly RJ; Monash University Clayton, Victoria Australia., Ekert PG; Children's Cancer Institute Randwick, NSW Australia., Fleuren EDG; Children's Cancer Institute Sydney, NSW Australia.
Source: Molecular cancer therapeutics [Mol Cancer Ther] 2026 Mar 19. Date of Electronic Publication: 2026 Mar 19.
Publication Type: Journal Article
Journal Info: Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41850747
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Comprehensive multi-platform tyrosine kinase profiling reveals novel actionable FGFR aberrations across sarcomas affecting the young.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Fordham+AM%22">Fordham AM</searchLink>; Children's Cancer Institute Australia Randwick Australia.<br /><searchLink fieldCode="AU" term="%22Brown+LM%22">Brown LM</searchLink>; Children's Cancer Institute Australia Sydney Australia.<br /><searchLink fieldCode="AU" term="%22Mayoh+C%22">Mayoh C</searchLink>; Children's Cancer Institute Australia Sydney, NSW Australia.<br /><searchLink fieldCode="AU" term="%22Salib+A%22">Salib A</searchLink>; Children's Cancer Institute Australia for Medical Research Sydney, NSW Australia.<br /><searchLink fieldCode="AU" term="%22Barger+ZA%22">Barger ZA</searchLink>; Children's Cancer Institute Australia Randwick Australia.<br /><searchLink fieldCode="AU" term="%22Wong+M%22">Wong M</searchLink>; Children's Cancer Institute Australia Kensington Australia.<br /><searchLink fieldCode="AU" term="%22Lim+Kam+Sian+TCC%22">Lim Kam Sian TCC</searchLink>; Monash University Clayton, Victoria Australia.<br /><searchLink fieldCode="AU" term="%22Hu+C%22">Hu C</searchLink>; Monash University Clayton Australia.<br /><searchLink fieldCode="AU" term="%22Xie+J%22">Xie J</searchLink>; Children's Cancer Institute Australia Sydney, NSW Australia.<br /><searchLink fieldCode="AU" term="%22Gunther+K%22">Gunther K</searchLink>; University of New South Wales Sydney, NSW Australia.<br /><searchLink fieldCode="AU" term="%22Trebilcock+P%22">Trebilcock P</searchLink>; Children's Cancer Institute Australia Randwick Australia.<br /><searchLink fieldCode="AU" term="%22Terry+RL%22">Terry RL</searchLink>; Children's Cancer Institute Australia Randwick Australia.<br /><searchLink fieldCode="AU" term="%22Barahona+P%22">Barahona P</searchLink>; Children's Cancer Institute Australia Sydney, NSW Australia.<br /><searchLink fieldCode="AU" term="%22Ajuyah+P%22">Ajuyah P</searchLink>; Children's Cancer Institute Australia Sydney, NSW Australia.<br /><searchLink fieldCode="AU" term="%22Sherstyuk+A%22">Sherstyuk A</searchLink>; Thermo Fisher Scientific Sydney, NSW Australia.<br /><searchLink fieldCode="AU" term="%22Avila+A%22">Avila A</searchLink>; Children's Cancer Institute Australia Kensington, NSW Australia.<br /><searchLink fieldCode="AU" term="%22Cadiz+R%22">Cadiz R</searchLink>; Children's Cancer Institute Australia Sydney, NSW Australia.<br /><searchLink fieldCode="AU" term="%22Perkins+CM%22">Perkins CM</searchLink>; Children's Cancer Institute Sydney, NSW Australia.<br /><searchLink fieldCode="AU" term="%22Gifford+AJ%22">Gifford AJ</searchLink>; Children's Cancer Institute Australia Randwick, NSW Australia.<br /><searchLink fieldCode="AU" term="%22Mao+J%22">Mao J</searchLink>; Children's Cancer Institute Australia Kensington, NSW Australia.<br /><searchLink fieldCode="AU" term="%22Dolman+MEM%22">Dolman MEM</searchLink>; Children's Cancer Institute Australia Kensington, NSW Australia.<br /><searchLink fieldCode="AU" term="%22Zhao+A%22">Zhao A</searchLink>; Children's Cancer Institute Australia Randwick Australia.<br /><searchLink fieldCode="AU" term="%22O'Regan+LP%22">O'Regan LP</searchLink>; Children's Cancer Institute Australia Randwick Australia.<br /><searchLink fieldCode="AU" term="%22Gorgels+D%22">Gorgels D</searchLink>; KU Leuven Leuven Belgium.<br /><searchLink fieldCode="AU" term="%22Lau+LMS%22">Lau LMS</searchLink>; Sydney Children's Hospital Randwick, NSW Australia.<br /><searchLink fieldCode="AU" term="%22Ziegler+DS%22">Ziegler DS</searchLink>; Sydney Children's Hospital Randwick, NSW Australia.<br /><searchLink fieldCode="AU" term="%22Haber+M%22">Haber M</searchLink>; Children's Cancer Institute Australia RANDWICK, NSW Australia.<br /><searchLink fieldCode="AU" term="%22Tyrrell+V%22">Tyrrell V</searchLink>; Children's Cancer Institute Australia Australia.<br /><searchLink fieldCode="AU" term="%22Lock+RB%22">Lock RB</searchLink>; Children's Cancer Institute Australia Sydney, NSW Australia.<br /><searchLink fieldCode="AU" term="%22Cowley+MJ%22">Cowley MJ</searchLink>; Children's Cancer Institute Australia Randwick, NSW Australia.<br /><searchLink fieldCode="AU" term="%22Nicholls+W%22">Nicholls W</searchLink>; Queensland Children's Hospital Brisbane, Queensland Australia.<br /><searchLink fieldCode="AU" term="%22Daly+RJ%22">Daly RJ</searchLink>; Monash University Clayton, Victoria Australia.<br /><searchLink fieldCode="AU" term="%22Ekert+PG%22">Ekert PG</searchLink>; Children's Cancer Institute Randwick, NSW Australia.<br /><searchLink fieldCode="AU" term="%22Fleuren+EDG%22">Fleuren EDG</searchLink>; Children's Cancer Institute Sydney, NSW Australia.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101132535%22">Molecular cancer therapeutics</searchLink> [Mol Cancer Ther] 2026 Mar 19. <i>Date of Electronic Publication: </i>2026 Mar 19.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%2C+Inc%22">American Association for Cancer Research, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101132535 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1538-8514 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215357163%22">15357163 </searchLink><i>NLM ISO Abbreviation: </i>Mol Cancer Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41850747
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/1535-7163.MCT-25-0736
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Comprehensive multi-platform tyrosine kinase profiling reveals novel actionable FGFR aberrations across sarcomas affecting the young.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Fordham AM
      – PersonEntity:
          Name:
            NameFull: Brown LM
      – PersonEntity:
          Name:
            NameFull: Mayoh C
      – PersonEntity:
          Name:
            NameFull: Salib A
      – PersonEntity:
          Name:
            NameFull: Barger ZA
      – PersonEntity:
          Name:
            NameFull: Wong M
      – PersonEntity:
          Name:
            NameFull: Lim Kam Sian TCC
      – PersonEntity:
          Name:
            NameFull: Hu C
      – PersonEntity:
          Name:
            NameFull: Xie J
      – PersonEntity:
          Name:
            NameFull: Gunther K
      – PersonEntity:
          Name:
            NameFull: Trebilcock P
      – PersonEntity:
          Name:
            NameFull: Terry RL
      – PersonEntity:
          Name:
            NameFull: Barahona P
      – PersonEntity:
          Name:
            NameFull: Ajuyah P
      – PersonEntity:
          Name:
            NameFull: Sherstyuk A
      – PersonEntity:
          Name:
            NameFull: Avila A
      – PersonEntity:
          Name:
            NameFull: Cadiz R
      – PersonEntity:
          Name:
            NameFull: Perkins CM
      – PersonEntity:
          Name:
            NameFull: Gifford AJ
      – PersonEntity:
          Name:
            NameFull: Mao J
      – PersonEntity:
          Name:
            NameFull: Dolman MEM
      – PersonEntity:
          Name:
            NameFull: Zhao A
      – PersonEntity:
          Name:
            NameFull: O'Regan LP
      – PersonEntity:
          Name:
            NameFull: Gorgels D
      – PersonEntity:
          Name:
            NameFull: Lau LMS
      – PersonEntity:
          Name:
            NameFull: Ziegler DS
      – PersonEntity:
          Name:
            NameFull: Haber M
      – PersonEntity:
          Name:
            NameFull: Tyrrell V
      – PersonEntity:
          Name:
            NameFull: Lock RB
      – PersonEntity:
          Name:
            NameFull: Cowley MJ
      – PersonEntity:
          Name:
            NameFull: Nicholls W
      – PersonEntity:
          Name:
            NameFull: Daly RJ
      – PersonEntity:
          Name:
            NameFull: Ekert PG
      – PersonEntity:
          Name:
            NameFull: Fleuren EDG
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 19
              M: 03
              Text: 2026 Mar 19
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1538-8514
          Titles:
            – TitleFull: Molecular cancer therapeutics
              Type: main
ResultId 1